Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (11375)	11/18/1997 4:44:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 32384

>>However, we may need a few more negative posts from Andy to really get the price moving north big time.<< &^%$#@^&()_+(&^%$$&#@$%&%$ Damn stock is worthless. Time to sell. Never will earn a penny. Not even worth the $1.30 a share that Vectorvest suggests. How many more do I need? >>Since we are almost at the 1 year anniversay of LGND's move from 11 1/4 to 17, culminating on their H&Q presentation on Jan 7, its probably time to start explaining why this year's move will be bigger and better (and why LGND is a steal at $14).<< I think you've already explained it many times, Henry. You have to convince the big boys now.

To: Henry Niman who wrote (11375)	11/18/1997 10:50:00 PM
From: Flagrante Delictu	Read Replies (2) \| Respond to of 32384

Henry, >>Will you be at... the RS & HQ conferences?<< I Hope to, unless I get such a massive margin call that I can't afford to.;] By the way, it is not implausible that if the viewpoint of the articles that you expect to soon be published revolves around the metabolic collaboration with Lilly, that such articles will have to await the actual formalization of the deal, which is contingent on the ALRI deal culminating first. Also, it may have been a mistake to let one of our threadsters drag out of you the name Business Week Online. Since Business Week has had previous incidents of articles being known before publication, the public attestation that it was upcoming, may have delayed or even eliminated that specific article . Thefore, he who had to know the name of the publication before he had any right to, may have unwittingly caused its cancellation. But my money is on you being right about the articles, even though you possibly may have understated the number of them rather than overoverstated them. Bernie.